These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37951410)

  • 1. Immunogenicity and protective efficacy of a recombinant adenovirus containing the fusion protein of bovine parainfluenza virus type 3 genotype C in mice.
    Zhang J; Zeng J; Yuan Z; Huang X; Wu J; Yu Q; Chen T; Den G; Zhu C; Zhang B
    Microb Pathog; 2023 Dec; 185():106444. PubMed ID: 37951410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three antigen epitopes on the nucleocapsid protein of the genotype C of bovine parainfluenza virus type 3.
    Ren JL; Zhu YM; Zhou YH; Lv C; Yan H; Ma L; Shi HF; Xue F
    Vet Microbiol; 2015 Jul; 178(1-2):61-9. PubMed ID: 25960335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins expressed by adenovirus recombinants.
    Mittal SK; Tikoo SK; van den Hurk JV; Breker-Klassen MM; Yoo D; Babiuk LA
    Intervirology; 1998; 41(6):253-60. PubMed ID: 10325535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A
    J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV.
    Haller AA; Mitiku M; MacPhail M
    J Gen Virol; 2003 Aug; 84(Pt 8):2153-2162. PubMed ID: 12867647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of a genotype C strain of bovine parainfluenza virus type 3 infection in albino guinea pigs.
    Shi HF; Zhu YM; Dong XM; Cai H; Ma L; Wang S; Yan H; Wang XZ; Xue F
    Virus Res; 2014 Aug; 188():1-7. PubMed ID: 24681303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
    Moffatt S; Hays J; HogenEsch H; Mittal SK
    Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic and antigenic analysis of bovine parainfluenza virus type 3 isolated in Japan between 2002 and 2019.
    Kumagai A; Kanno T; Kawauchi K; Tanaka K; Ishihara R; Hatama S
    Vet Microbiol; 2020 Aug; 247():108774. PubMed ID: 32768220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
    Pandey A; Singh N; Vemula SV; Couëtil L; Katz JM; Donis R; Sambhara S; Mittal SK
    PLoS One; 2012; 7(3):e33428. PubMed ID: 22432020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.
    Skiadopoulos MH; Schmidt AC; Riggs JM; Surman SR; Elkins WR; St Claire M; Collins PL; Murphy BR
    J Virol; 2003 Jan; 77(2):1141-8. PubMed ID: 12502830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
    Liang B; Matsuoka Y; Le Nouën C; Liu X; Herbert R; Swerczek J; Santos C; Paneru M; Collins PL; Buchholz UJ; Munir S
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
    Liang B; Ngwuta JO; Surman S; Kabatova B; Liu X; Lingemann M; Liu X; Yang L; Herbert R; Swerczek J; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled BPIV3 nanoparticles can induce comprehensive immune responses and protection against BPIV3 challenge by inducing dendritic cell maturation in mice.
    Qu Z; Li M; An R; Dai H; Yu Y; Li C; Cao C; Meng Y; Wang J; Gao M
    Vet Microbiol; 2022 May; 268():109415. PubMed ID: 35395543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a photocontrollable recombinant bovine parainfluenza virus type 3.
    Okura T; Tahara M; Otsuki N; Sato M; Takeuchi K; Takeda M
    Microbiol Immunol; 2023 Apr; 67(4):204-209. PubMed ID: 36609846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.
    Breker-Klassen MM; Yoo D; Mittal SK; Sorden SD; Haines DM; Babiuk LA
    J Virol; 1995 Jul; 69(7):4308-15. PubMed ID: 7769692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and genetic characterization of bovine parainfluenza virus type 3 from cattle in China.
    Zhu YM; Shi HF; Gao YR; Xin JQ; Liu NH; Xiang WH; Ren XG; Feng JK; Zhao LP; Xue F
    Vet Microbiol; 2011 May; 149(3-4):446-51. PubMed ID: 21131145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.